The Low Back Pain Clinical Care Standard will help to improve early management of patients with this common condition and reduce their chance of ongoing problems.
This infographic highlights the scale of low back pain as a health issue in Australia, the disability burden and 6 steps for patients to help manage their pain.
This issue includes items on the forthcoming Low Back Pain Clinical Care Standard, updated infection prevention and control training, virtual wards and Hospital in the home, My Health Record in emergency departments, diagnostic safety, palliative care, safety culture, COVID-19 and more.
Also covered are the latest issues of the Journal of Patient Safety and Healthcare Quarterly along with early online papers from BMJ Quality & Safety and the International Journal for Quality in Health Care.
The Low Back Pain Clinical Care Standard has been endorsed by a number of key health organisations:
Show your support for the clinical care standard by downloading and sharing the content on your website, social networks or within your health service. You are encouraged to use these resources to raise awareness about the new standard and best practice care for low back pain.
The Low Back Pain Clinical Care Standard was developed by the Commission, in partnership with health service organisations, clinicians and consumers. See endorsing organisations
This issue includes items on the forthcoming Low Back Pain Clinical Care Standard, the new UK’s Patient Safety Incident Response Framework, self-harm, arterial lines, unacceptable behaviour between healthcare workers, emergency departments, resilient healthcare, COVID-19 and more.
Also covered are the latest issues of BMJ Quality & Safety and the Australian Journal of Primary Health along with the latest from the UK’s NICE.
This fact sheet provides practical information about how to use the Australian Charter of Healthcare Rights in your health service.
Download the standard
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard aims to ensure the safe and appropriate use of psychotropic medicines in people with cognitive disability or impairment.
This report provides analyses of trends for resistance to third-generation cephalosporins, such as ceftriaxone, in E. coli and K. pneumoniae captured through APAS from 2006 to 2021.